Vivace Therapeutics, Inc.
BiotechnologyBiotechnology - Cancer Treatments
San Mateo, CA
About
Vivace Therapeutics, Inc. is a pioneering biotechnology firm focused on creating innovative cancer treatments that specifically target the Hippo-YAP signaling pathway. The company aims to deliver solutions for cancer patients with limited options, particularly those suffering from challenging malignancies driven by pathway dysregulation.
Company Values
Vivace stands out by focusing on the Hippo pathway, which is often overlooked in cancer research, and has developed VT3989—a promising small molecule drug that has shown early success in clinical trials.